112 related articles for article (PubMed ID: 21289517)
1. Aromatase inhibitor exemestane has antiproliferative effects on human mesothelioma cells.
Stoppoloni D; Salvatori L; Biroccio A; D'Angelo C; Muti P; Verdina A; Sacchi A; Vincenzi B; Baldi A; Galati R
J Thorac Oncol; 2011 Mar; 6(3):583-91. PubMed ID: 21289517
[TBL] [Abstract][Full Text] [Related]
2. Modulation of reactive oxygen species via ERK and STAT3 dependent signalling are involved in the response of mesothelioma cells to exemestane.
Nuvoli B; Camera E; Mastrofrancesco A; Briganti S; Galati R
Free Radic Biol Med; 2018 Feb; 115():266-277. PubMed ID: 29229551
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel COX-2 / CYP19A1 axis involved in the mesothelioma pathogenesis opens new therapeutic opportunities.
Nuvoli B; Antoniani B; Libener R; Maconi A; Sacconi A; Carosi M; Galati R
J Exp Clin Cancer Res; 2021 Aug; 40(1):257. PubMed ID: 34404424
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and mechanism of action of Proellex, an antiprogestin in aromatase overexpressing and Letrozole resistant T47D breast cancer cells.
Gupta A; Mehta R; Alimirah F; Peng X; Murillo G; Wiehle R; Mehta RG
J Steroid Biochem Mol Biol; 2013 Jan; 133():30-42. PubMed ID: 22939887
[TBL] [Abstract][Full Text] [Related]
5. Treatment of aromatase (CYP19A1) inhibitor reduces fertility in porcine sperm.
Oh JN; Hwang JY; Choi KH; Lee CK
Zygote; 2016 Feb; 24(1):98-106. PubMed ID: 25621494
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor enhances SN38-mediated apoptosis in mesothelioma cells: the role of nuclear factor-kappaB pathway activation.
Russo P; Catassi A; Malacarne D; Margaritora S; Cesario A; Festi L; Mulé A; Ferri L; Granone P
Cancer; 2005 Apr; 103(7):1503-18. PubMed ID: 15700263
[TBL] [Abstract][Full Text] [Related]
7. New cell culture model for aromatase inhibitor-resistant breast cancer shows sensitivity to fulvestrant treatment and cross-resistance between letrozole and exemestane.
Hole S; Pedersen AM; Hansen SK; Lundqvist J; Yde CW; Lykkesfeldt AE
Int J Oncol; 2015 Apr; 46(4):1481-90. PubMed ID: 25625755
[TBL] [Abstract][Full Text] [Related]
8. Estrogen signaling is active in cartilaginous tumors: implications for antiestrogen therapy as treatment option of metastasized or irresectable chondrosarcoma.
Cleton-Jansen AM; van Beerendonk HM; Baelde HJ; Bovée JV; Karperien M; Hogendoorn PC
Clin Cancer Res; 2005 Nov; 11(22):8028-35. PubMed ID: 16299232
[TBL] [Abstract][Full Text] [Related]
9. Exemestane metabolites: Synthesis, stereochemical elucidation, biochemical activity and anti-proliferative effects in a hormone-dependent breast cancer cell line.
Varela CL; Amaral C; Tavares da Silva E; Lopes A; Correia-da-Silva G; Carvalho RA; Costa SC; Roleira FM; Teixeira N
Eur J Med Chem; 2014 Nov; 87():336-45. PubMed ID: 25277066
[TBL] [Abstract][Full Text] [Related]
10. Aromatase expression in ovarian epithelial cancers.
Cunat S; Rabenoelina F; Daurès JP; Katsaros D; Sasano H; Miller WR; Maudelonde T; Pujol P
J Steroid Biochem Mol Biol; 2005 Jan; 93(1):15-24. PubMed ID: 15748828
[TBL] [Abstract][Full Text] [Related]
11. Antiproliferative effect of exemestane in lung cancer cells.
Koutras A; Giannopoulou E; Kritikou I; Antonacopoulou A; Evans TR; Papavassiliou AG; Kalofonos H
Mol Cancer; 2009 Nov; 8():109. PubMed ID: 19930708
[TBL] [Abstract][Full Text] [Related]
12. Expression of the embryonic lethal abnormal vision-like protein HuR in human mesothelioma: association with cyclooxygenase-2 and prognosis.
Stoppoloni D; Cardillo I; Verdina A; Vincenzi B; Menegozzo S; Santini M; Sacchi A; Baldi A; Galati R
Cancer; 2008 Nov; 113(10):2761-9. PubMed ID: 18831511
[TBL] [Abstract][Full Text] [Related]
13. Theoretical Study of the Mechanism of Exemestane Hydroxylation Catalyzed by Human Aromatase Enzyme.
Viciano I; Martí S
J Phys Chem B; 2016 Apr; 120(13):3331-43. PubMed ID: 26972150
[TBL] [Abstract][Full Text] [Related]
14. Melatonin suppresses aromatase expression and activity in breast cancer associated fibroblasts.
Knower KC; To SQ; Takagi K; Miki Y; Sasano H; Simpson ER; Clyne CD
Breast Cancer Res Treat; 2012 Apr; 132(2):765-71. PubMed ID: 22237979
[TBL] [Abstract][Full Text] [Related]
15. Aromatase inhibitor treatment of breast cancer cells increases the expression of let-7f, a microRNA targeting CYP19A1.
Shibahara Y; Miki Y; Onodera Y; Hata S; Chan MS; Yiu CC; Loo TY; Nakamura Y; Akahira J; Ishida T; Abe K; Hirakawa H; Chow LW; Suzuki T; Ouchi N; Sasano H
J Pathol; 2012 Jul; 227(3):357-66. PubMed ID: 22407818
[TBL] [Abstract][Full Text] [Related]
16. Aromatase destabilizer: novel action of exemestane, a food and drug administration-approved aromatase inhibitor.
Wang X; Chen S
Cancer Res; 2006 Nov; 66(21):10281-6. PubMed ID: 17079446
[TBL] [Abstract][Full Text] [Related]
17. Increased intratumoral androgens in human breast carcinoma following aromatase inhibitor exemestane treatment.
Takagi K; Miki Y; Nagasaki S; Hirakawa H; Onodera Y; Akahira J; Ishida T; Watanabe M; Kimijima I; Hayashi S; Sasano H; Suzuki T
Endocr Relat Cancer; 2010 Jun; 17(2):415-30. PubMed ID: 20228125
[TBL] [Abstract][Full Text] [Related]
18. Effects of a combination of exemestane and paclitaxel on human tumor cells in vitro.
Chen D; Hackl W; Ortmann O; Treeck O
Anticancer Drugs; 2004 Jan; 15(1):55-61. PubMed ID: 15090744
[TBL] [Abstract][Full Text] [Related]
19. 1,25-dihydroxyvitamin D3 downregulates aromatase expression and inflammatory cytokines in human macrophages.
Villaggio B; Soldano S; Cutolo M
Clin Exp Rheumatol; 2012; 30(6):934-8. PubMed ID: 23253631
[TBL] [Abstract][Full Text] [Related]
20. Effects of aromatase inhibitors on human osteoblast and osteoblast-like cells: a possible androgenic bone protective effects induced by exemestane.
Miki Y; Suzuki T; Hatori M; Igarashi K; Aisaki KI; Kanno J; Nakamura Y; Uzuki M; Sawai T; Sasano H
Bone; 2007 Apr; 40(4):876-87. PubMed ID: 17254854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
